-
The 67-year-old minister was given the first shot on November 20.
-
Biden, who is due to take office on January 20, said he will make sure that the vaccine is both free and available.
-
As production of the two vaccines expands, 20 million will be reached in December, 30 million in January and 50 million in February, making 100 million total.
-
The move comes a day after rival Moderna said it was asking US and European regulators to allow emergency use of its COVID-19 vaccine.
-
Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August.
-
Modi began his three-city visit on Saturday to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad in the morning.
-
Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.
-
Zydus Cadila had announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.
-
Bolsonaro faces criticism for his handling of the pandemic, which has included playing down the virus, opposing lockdown measures.
-
Modi will be arriving at Hakimpet Air Force station in an IAF flight from Pune in the afternoon, an official memo issued by the Telangana Chief Secretary on Thursday night said.
-
The Hyderabad-based firm, while applying for phase-three trial, stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported.
-
He had offered to be the first volunteer for the third phase trial of Covaxin, which started in the state today.
-
The team is also testing whether the vaccine stops people developing COVID-19 in larger Phase 3 trials and early results from this crucial stage are expected in the coming weeks.
-
Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.
-
Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.
-
Dr. Saul Faust, who is helping lead the study, said the research will start first in Britain but aims to recruit a total of 30,000 people in six countries around the world.
-
Union Finance Minister and BJP leader Nirmala Sitharaman released the party's manifesto.
-
The World Health Organisation (WHO) has identified 42 candidate vaccines in clinical trials, ten of which are in the most advanced "phase 3" stage.
-
Harris also said that if there is a coronavirus vaccine available during Trump's administration that is not embraced by scientific advisers, she will not take it.
-
Many experts also believe that there may be some false starts before an effective vaccine is available.